This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

KS01017

AbbVie Inc.

Drug Names(s): KS-01-017

Description: KS-01-017 is a dual regulator of glucose and lipids, which is expected to have lipid effects similar to Niaspan.

Deal Structure: In December 2006, Abbott Laboratories closed its acquisition of Kos Pharmaceuticals.


KS01017 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug